Ally Financial’s Gilead Sciences GILD Stock Holding History

Ally Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-70,000	Closed	-$5.87M	–	114
2024 Q3	$5.87M	Hold	70,000	–	–	0.71%	30
2024 Q2	$4.8M	Hold	70,000	–	–	0.6%	47
2024 Q1	$5.13M	Hold	70,000	–	–	0.69%	39
2023 Q4	$5.67M	Hold	70,000	–	–	0.74%	32
2023 Q3	$5.25M	Hold	70,000	–	–	0.77%	35
2023 Q2	$5.39M	Hold	70,000	–	–	0.75%	32
2023 Q1	$5.81M	Hold	70,000	–	–	0.86%	31
2022 Q4	$6.01M	Hold	70,000	–	–	0.94%	32
2022 Q3	$4.32M	Hold	70,000	–	–	0.71%	41
2022 Q2	$4.33M	Hold	70,000	–	–	0.59%	45
2022 Q1	$4.16M	Hold	70,000	–	–	0.48%	51
2021 Q4	$5.08M	Hold	70,000	–	–	0.47%	53
2021 Q3	$4.89M	Hold	70,000	–	–	0.48%	54
2021 Q2	$4.82M	Hold	70,000	–	–	0.48%	63
2021 Q1	$4.52M	Hold	70,000	–	–	0.43%	62
2020 Q4	$4.08M	Hold	70,000	–	–	0.38%	67
2020 Q3	$4.42M	Hold	70,000	–	–	0.71%	48
2020 Q2	$5.39M	Hold	70,000	–	–	0.89%	34
2020 Q1	$5.23M	Hold	70,000	–	–	0.56%	33
2019 Q4	$4.55M	Hold	70,000	–	–	0.75%	39
2019 Q3	$4.44M	Hold	70,000	–	–	0.79%	43
2019 Q2	$4.73M	Hold	70,000	–	–	0.81%	39
2019 Q1	$4.55M	Hold	70,000	–	–	0.87%	36
2018 Q4	$4.38M	Hold	70,000	–	–	0.57%	33
2018 Q3	$5.41M	Hold	70,000	–	–	1.07%	27
2018 Q2	$4.96M	Hold	70,000	–	–	0.97%	33
2018 Q1	$5.28M	Hold	70,000	–	–	0.79%	28
2017 Q4	$5.01M	Hold	70,000	–	–	0.97%	27
2017 Q3	$5.67M	Hold	70,000	–	–	1.08%	27
2017 Q2	$4.96M	Buy	70,000 +5,000	+8%	+$333K	0.98%	34
2017 Q1	$4.42M	Hold	65,000	–	–	1%	32
2016 Q4	$4.66M	Hold	65,000	–	–	0.78%	35
2016 Q3	$5.14M	Hold	65,000	–	–	0.9%	22
2016 Q2	$5.42M	Buy	65,000 +5,000	+8%	+$444K	0.91%	29
2016 Q1	$5.51M	Buy	60,000 +10,000	+20%	+$902K	0.77%	31
2015 Q4	$5.06M	Hold	50,000	–	–	0.71%	39
2015 Q3	$4.91M	Buy	+50,000	New	+$5.55M	0.5%	51
2015 Q2	–	Sell	-90,000	Closed	-$8.83M	–	139
2015 Q1	$8.83M	Hold	90,000	–	–	0.91%	36
2014 Q4	$8.48M	Buy	+90,000	New	+$9.31M	0.94%	30
2014 Q3	–	Sell	-85,000	Closed	-$7.05M	–	141
2014 Q2	$7.05M	Buy	85,000 +25,000	+42%	+$1.95M	0.83%	38
2014 Q1	$4.25M	Sell	60,000 -25,000	-29%	-$1.96M	0.45%	81
2013 Q4	$6.39M	Buy	85,000 +5,000	+6%	+$348K	0.68%	51
2013 Q3	$5.03M	Hold	80,000	–	–	0.55%	69
2013 Q2	$4.1M	Buy	+80,000	New	+$4.17M	0.4%	90

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ally Financial's GILD Position: Q4 2024 in Review

Ally Financial sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 70,000 shares — an estimated $5.87M sold.

Ally Financial first reported a position in GILD in Q2 2013 and held it in 44 quarters. The position peaked at $8.83M in Q1 2015. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

Ally Financial reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
Ally Financial sold 70,000 Gilead Sciences shares in Q4 2024, an estimated $5.87M.
Ally Financial first reported a position in Gilead Sciences in Q2 2013 and held it in 44 quarters.
Ally Financial's Gilead Sciences position peaked at $8.83M in Q1 2015.
1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Ally Financial's 13F filing for Q4 2024, filed 13 Feb 2025.